BioLargo Balance Sheet - Quarterly (OTCMKTS:BLGO)

Add to My Stocks
$0.25 $0.03 (10.71%) BLGO stock closing price Aug 15, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at BioLargo balance sheet. How cash on hand has increased or decreased is one of the many indicators used while undertaking the BioLargo stock analysis, and provides insights into the firm's financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing BioLargo revenue BioLargo operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The BioLargo balance sheet for 2018 Q1 shows cash on hand of $-. The company has a debt to equity ratio of -.

View and download BioLargo quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash--1.25M-1.17M1.91M1.73M-1.02M1.76M
Marketable Securities----------
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
1.11M1.15M1.44M-1.4M2.01M1.87M1M1.17M1.89M
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
1.45M1.49M1.74M-1.49M2.11M1.96M1.02M1.19M1.91M
Notes Payable3.99M------1.54M1.51M-
Accounts Payable----------
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
5.05M4.21M3.61M3.73M-1.15M----
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt----2.24M1.72M1.24M---
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
6.07M4.9M4.14M4.11M3.12M2.88M2.12M1.45M--
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus98.6M97.09M95.76M92.53M91.82M90.6M88.92M86.16M85.14M84.41M
Retained Earnings-103.82M-101.2M-98.86M-96.25M-93.91M-91.91M-89.68M-87.26M-85.65M-84.07M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity-4.61M-3.4M-2.4M-3.47M-1.62M-0.77M-0.16M-0.42M-1.14M
Total Liabilities & Shareholders Equity1.45M1.49M1.74M-1.49M2.11M1.96M1.02M1.19M1.91M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest BioLargo stock price, and BioLargo historical stock prices show the stock price movement over time, and the BioLargo PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: Anything that the BioLargo company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. BioLargo had total assets of $1.45M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case BioLargo's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for BLGO stock stand at $6.07M.

BioLargo Balance Sheet - Key Ratios

Current ratio
0.22
Debt to equity ratio
0
Asset turnover ratio
0.71
Receivables turnover
8.49